Selective estrogen receptor modulators: A new brand of multitarget drugs

3Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The concept of selective estrogen receptor modulators (SERMs) has emerged recently in modern medicine. Two main features, the evidence of the wide expression of estrogen receptors in organs and systems and the growing information on the determinants of estrogen action, have allowed the envisioning of compounds with "a la carte" estrogenic profiles. The availability of substances performing as agonists wherever the estrogenic action is beneficial and as antagonists where it is not, is becoming less of a dream than of a closer reality. This book is an up-to-date review of the principal basic mechanisms and the clinical data integrating the actual current knowledge on SERMs. © Springer-Verlag Berlin Heidelberg 2006.

Cite

CITATION STYLE

APA

Sanchez, A. C., Alsina, J. C. I., & Dueñas-Díez, J. L. (2006). Selective estrogen receptor modulators: A new brand of multitarget drugs. Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (pp. 1–357). Springer Berlin Heidelberg. https://doi.org/10.1007/3-540-34742-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free